Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 5 | 0 | €979.60 | €1,034.6 | 5.618% |
| Eli Lilly Corp. | 62 | 1 | 8 | 1 | €775.90 | €824.47 | 6.259% |
| arGEN X BV | 1 | 0 | 0 | 0 | €458.00 | €470.00 | 2.620% |
| Vertex Pharmaceuticals Inc. | 54 | 2 | 4 | 0 | €451.75 | €440.93 | -2.396% |
| Medpace Holdings Inc | 17 | 0 | 6 | 0 | €353.80 | €418.12 | 18.180% |
| Icon plc | 22 | 0 | 1 | 0 | €296.20 | €326.56 | 10.249% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €260.00 | €315.00 | 21.154% |
| Amgen Inc. | 26 | 0 | 2 | 0 | €309.80 | €304.65 | -1.664% |
| Biogen Inc. | 53 | 1 | 4 | 0 | €209.00 | €292.26 | 39.836% |
| United Therapeutics | 23 | 0 | 2 | 0 | €305.00 | €290.24 | -4.840% |
| Alnylam Pharmace. | 46 | 0 | 8 | 0 | €218.30 | €250.79 | 14.883% |
| Charles River Labs Intl | 12 | 0 | 1 | 0 | €205.40 | €248.57 | 21.018% |
| BeiGene Ltd ADR | 9 | 1 | 0 | 0 | €145.00 | €241.54 | 66.582% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €165.54 | €200.06 | 20.851% |
| Johnson & Johnson | 39 | 1 | 4 | 0 | €143.88 | €195.31 | 35.742% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €190.80 | €186.59 | -2.206% |
| Jazz Pharmaceuticals plc | 27 | 0 | 1 | 0 | €100.40 | €184.92 | 84.183% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €121.20 | €182.96 | 50.957% |
| AbbVie Inc. | 28 | 0 | 4 | 0 | €159.24 | €176.30 | 10.714% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €141.35 | €165.00 | 16.732% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €125.00 | €150.00 | 20.000% |
| Merck KGaA | 3 | 2 | 0 | 1 | €152.95 | €146.00 | -4.544% |
| Novo Nordisk A/S ADR | 20 | 1 | 2 | 0 | €117.50 | €145.75 | 24.046% |
| Neurocrine Bioscience | 34 | 0 | 3 | 0 | €134.55 | €144.01 | 7.031% |